Atropine 0.01% Ophthalmic Solution

DRUG2 trials

Sponsors

Eyenovia Inc., University of California, Berkeley

Conditions

Myopia

Phase 1

An Investigation of Topical Ophthalmic Low-Dose Atropine on Pupil Size and Accommodation

CompletedNCT07674966

University of California, BerkeleyMyopia

Start: 2022-03-16End: 2022-10-09Updated: 2026-06-30

Phase 3

Microdosed Atropine 0.1% and 0.01% Ophthalmic Solutions for Reduction of Pediatric Myopia Progression

TerminatedNCT03942419

Eyenovia Inc.Myopia

Start: 2019-06-03End: 2024-11-20Updated: 2025-01-06